Seminars

Next seminar:  Alexandra Gruss, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France,

 

Remodelling Staphylococcus aureus membranes with host fatty acids and consequences on antibiotic adaptation

MONDAY   14. 10. 2019 , 11:30 -12:30

 

Room E07.3347.a (old numbering:7172) - CMU, otherwise indicated
DATE SPEAKER TITLE HOST INFORMATIONS
02.09.2019    

 P

 
09.09.2019 Arnau Domenech, Université de Lausanne Antibiotic resistance in Streptococcus pneumoniae - from epidemiology to fundamental biology  PL Domenech
16.09.2019  John McCarthy, University of Warwick Novel molecular architectures in theLeishmania translation machinery - potential drug targets? PL McCarthy
23.09.2019 Rebecca Corrigan,Department of Molecular Biology and Biotechnology, University of Sheffield Nucleotide signalling systems: Key players in bacterial stress adaptation  PL  Corrigan
30.09.2019 Fabien Darfeuille, Bordeaux Functional analysis of type I toxin-antitoxin systems in Helicobacter pylori PV Darfeuille
07.10.2019  Michal Wandel, Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biolog, Cambridge Biomedical Campus,Cambridge  Interferon-induced GTPases mediate anti-bacterial immunity  PL Wandel
14.10.2019 Alexandra Gruss, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy en Josas, France, Remodelling Staphylococcus aureus membranes with host fatty acids and consequences on antibiotic adaptation  VK &PL Gruss
21.10.2019 Marc Graille, Ecole Polytechnique, Palaiseau, France Trm112, a toolbox protein for RNA methyltransferases PL Graille
28.10.2019 Pr Marc Lipsitch, Department of Epidemiolog, Department of Immunology and Infectious Diseases, Harvard T.H. Chan Why haven't antibiotic-resistant bacteria taken over the world? SH Lipsitch
04.11.2019  Charles Dorman, Trinity College, Dublin    PL  
11.11.2019 Frederic Allain, Institut fur Molekularbiologie und Biophysik, ETH Zurich   PV &PL  
18.11.2019        
25.11.2019 Ilaria Di Resta, M.Sc.;IPMA| Medicines for Malaria Venture  Associate Director Translational Medicine  Defeating Malaria Together | www.mmv.org  Clinical drugs development overview and Malaria challenges and opportunities  DSF  
04.11.2019        
02.12.2019        
09.12.2019        
16.12.2019        
2020        
6.01.2020 Patrick Eichenberger,New York University, Department of Biology, Center for Genomics & Systems Biology    PL  
6.04.20120 Wolfram Zückert, Department of Microbiology, Molecular Genetics & Immunology, University of Kansas School of Medicine, Kansas City  to be communicated PL  

Contact: Patrick.Linder(at)unige.ch